The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases. | Read More in JPost.com – The Jerusalem Post – All News from the Middle East, Israel, and the Jewish World
State Attorney Aisman warns Mahash law could put sensitive cases under political pressure
Russia pumps up pressure on Belarus to open new front in Ukraine war, eyes anti-NATO ops. – WSJ
Taiwan’s Jewish community establishes first-ever cemetery in Taipei, buries 74-year-old man
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer IngelheimIran’s Quds Force chief tells Israel to leave Lebanon or face ‘humiliating defeat’
‘Dabash is dead. Get here. Now’: IDF officer takes command in battalion’s darkest hour
Hesder yeshivas back down from IDF Armored Corps boycott over female tank crews
Saudi Arabia just bought eyes in the sky over Sinai — pointed straight at Israel
‘You have to be blind’: Netanyahu defends war’s successes
Kenneth Abramowitz: ‘Mr. President, we voted for victory, not endless war’
‘Israel is far from a proxy of the US, Netanyahu will defend Israel’s interests’
From Today’s Tears Will Grow Tomorrow’s GoodAlphabet takes its place in the Dow Jones industrial averageWhen institutions lose trust, who earns it? – opinionWhen institutions lose trust, who earns it? – opinionIran’s Quds Force chief tells Israel to leave Lebanon or face ‘humiliating defeat’